Neurology and Neurosurgery

Episodes 16-30 of 124

• 

  RestartResume

  Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development

  MinuteCE®

  Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Mapping the Mind: The Pathophysiology That Drives AAD

  MinuteCE®

  Mapping the Mind: The Pathophysiology That Drives AAD

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  AAD Treatment Evolution: The Future of Emerging Therapies

  MinuteCE®

  AAD Treatment Evolution: The Future of Emerging Therapies

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  MinuteCE®

  Proactive Screening: Essential Tools for Diagnosing AAD Quickly

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD

  MinuteCE®

  Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know

  MinuteCE®

  Early Warning: Clinical Signs of AAD Every PCP and Caregiver Should Know

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care

  MinuteCE®

  Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review

  CME/CE

  Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  0.25 credits

• 

  RestartResume

  Team Approach: Enhancing Collaboration in AAD Management

  MinuteCE®

  Team Approach: Enhancing Collaboration in AAD Management

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  MinuteCE®

  Optimizing Outcomes in AAD in Community PCP and LTC Clinics

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 credits 11 episodes

• 

  RestartResume

  Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice

  MinuteCE®

  Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  MinuteCE®

  Caregiver Screening Tools for Agitation in Alzheimer’s Disease

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Optimizing Outcomes in AAD in Community PCP and LTC Clinics

  CME/CE

  Optimizing Outcomes in AAD in Community PCP and LTC Clinics

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  0.25 credits

• 

  RestartResume

  Burden Beyond the Patient: AAD's Impact on Patients and Caregivers

  MinuteCE®

  Burden Beyond the Patient: AAD's Impact on Patients and Caregivers

  • 

    

    C. Brendan Montano, MD

    Peer

  • 

    

    Anton P. Porsteinsson, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans

  CME/CE

  Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans

  • 

    

    Michael Erdman, PharmD, BCCCP

    Peer

  • 

    

    Ali A. Habib, MD

    Peer

  1.00 credits

• Prev
• 1
• 2
• 3
• 4
• …
• 8
• 9
• Next